Technology News and Research

RSS

Navicure adds two Minnesota-based organizations to its client roster

Navicure, a leading Internet-based medical claims clearinghouse for physician practices, today announced the addition of two Minnesota-based organizations to its client roster. Heartland Orthopedic Specialists and Fond du Lac Human Services both selected Navicure’s award-winning account receivables management solutions to improve claims management and increase profitability.

21 Sep 2009

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), reported today that it has signed a “Master Service Agreement” with the Southern Research Institute (“Southern Research”), Birmingham, AL. Southern Research is a well established, prestigious institution that has performed preclinical testing services for several vaccines and antivirals.

21 Sep 2009

Memorial Medical Center deploys Motorola's 802.11n WLAN solution to improve patient care

The Enterprise Mobility Solutions business of Motorola, Inc. (NYSE: MOT), today announced that Lowry Computer, a leading systems integrator and Motorola channel partner, has deployed its 802.11n wireless LAN (WLAN) solution at Memorial Medical Center (MMC) of Western Michigan, a community hospital located in Ludington, Mich.

21 Sep 2009

Geron and Corning develop synthetic surface that supports the growth and differentiation of hESCs

Corning Incorporated (NYSE: GLW) and Geron Corporation (Nasdaq: GERN) today announced the successful development of novel synthetic surface matrices demonstrated to enhance and support the scalable manufacturing and growth of human embryonic stem cells (hESCs).

21 Sep 2009

GE Capital deploys $1 billion in the U.S. healthcare market for the first six months of 2009

GE Capital’s Healthcare Financial Services business ended the first six months of 2009 as one of the most active capital providers in the U.S. healthcare market, deploying approximately $1 billion for more than 45 transactions. Loans were used to refinance existing debt, support working capital needs and fund growth initiatives.

21 Sep 2009

Phytel releases new version of its web-based Proactive Patient Outreach Solution

Phytel, the leading provider of information technology that empowers physician-led health improvement, today announced that version 5 of its web-based Proactive Patient Outreach Solution has been released and fully deployed to all of its customers.

21 Sep 2009

Primeradx raises funds for commercialization of their technology

PrimeraDx, Inc., a privately held molecular diagnostics company, announced today that it has closed on its $20 million Series C financing. The financing was led by CHL Medical Partners and also included significant participation by many of the Company’s existing investors; Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Company and the Invus Group.

21 Sep 2009

Maxygen completes joint venture transaction with Astellas Pharma

Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on September 18, 2009, the parties established a newly-formed joint venture, Perseid Therapeutics LLC, to focus on the discovery, research and development of multiple protein pharmaceutical programs.

21 Sep 2009

Two new products released by Simbionix USA Corporation

Simbionix USA Corporation, the world's leading developer of medical simulation systems, just released two new products: a new Laparoscopic Essential Tasks Module for its LAP Mentor(TM) and a breakthrough technology for patient-specific simulation based on actual patient data - the PROcedure Rehearsal Studio(TM).

21 Sep 2009

BRS Labs announces a video-surveillance technology that processes visual data like human brain

Behavioral Recognition Systems (BRS Labs) today announces a ground-breaking video-surveillance technology called Behavioral Analytics™, which leverages cognitive reasoning, and processes visual data on a level similar to the human brain.

21 Sep 2009

Study reveals that Europe must change perspectives towards food security

A new report by leading food and sustainability scientists calls for Europe to take a new approach on food security, prioritizing health and sustainability in research and using a holistic view when making policy. The report has been jointly chaired by Peter Raspor, professor of food science and technology at the University of Ljubljana, Slovenia and Rudy Rabbinge, professor of sustainable development and systems innovation at Wageningen University, the Netherlands.

21 Sep 2009

Sandia National Laboratories awards equipment contract to Arrayit Corporation

Arrayit Corporation (OTCBB: ARYC), a proprietary life sciences and nanotechnology technology leader, announces that on September 11th, 2009 Arrayit delivered its proprietary nanotechnology platform to Sandia National Laboratories in Albuquerque, New Mexico. Sandia Labs, managed by the Lockheed Martin Corporation, works with the Transportation Security Administration (TSA) and the Department of Homeland Security to enhance national security.

21 Sep 2009

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

DOR BioPharma, Inc. (OTC Bulletin Board: DORB) (DOR or the Company), a late-stage biotechnology company, announced today that it has been awarded an approximate $9.4 Million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).

21 Sep 2009

Failures in Canadian health policy

As America grapples with reforming health care with an eye to introducing a public option, a new book published by the Fraser Institute, one of Canada’s leading economic think tanks, details the failures of Canada’s government-run health care system and serves as a warning to U.S. policy-makers.

21 Sep 2009

AstraZeneca and Nektar Therapeutics enter worldwide license agreement for two drug development programmes

AstraZeneca and Nektar Therapeutics announced today that they have entered into an exclusive worldwide license agreement for two drug development programmes: NKTR-118, a late stage investigational product being evaluated for the treatment of opioid-induced constipation, and the NKTR-119 programme, an early stage programme that is intended to deliver products for the treatment of pain without constipation side effects.

21 Sep 2009

NIAID awards Antigen Discovery a Phase II STTR grant for Chlamydia vaccine development

Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.

21 Sep 2009

Optimized diabetes management with the CONTOUR(R) USB blood glucose meter

Bayer Diabetes Care today announced U.S. Food & Drug Administration clearance to market the CONTOUR(R) USB blood glucose meter. Bayer's CONTOUR USB meter is the first and only blood glucose monitor that plugs directly into a computer providing users with instant access to information that can help optimize diabetes management. The CONTOUR USB meter is integrated with Glucofacts(TM) DELUXE software for easy retrieval of data as well as longer-term tracking and analysis of blood glucose test results.

21 Sep 2009

Better visualization of soft tissues using Toshiba's LCI

To continue its commitment to advancing medical imaging technology and improving diagnosis, Toshiba America Medical Systems, Inc. introduces Low-Contrast Imaging (LCI) for Toshiba’s InfinixTM-i systems with mid (12” x 12”) and large (12” x 16”) flat-panel detectors (FPD). Toshiba will demonstrate its low-contrast imaging capabilities at this year’s Transcatheter Cardiovascular Therapeutics (TCT) annual meeting in San Francisco, Sept. 21 – Sept. 25, 2009 (Booth #705).

21 Sep 2009

Ontarians support research involving biotechnology

Ontarians overwhelmingly value biotechnology’s contribution to their lives and the economy, BIOTECanada told Minister Milloy and an audience of over 150 business leaders at the launch of the sixth annual National Biotechnology Week.

21 Sep 2009

The 2009 National Pharmacy Study ranks Prescription Solutions second among mail order pharmacies

Prescription Solutions, a leading pharmacy benefits management (PBM) organization and a UnitedHealth Group (NYSE:UNH) company, today announced that it received the highest rankings for customer service and cost competitiveness factors among mail order pharmacies in the J.D. Power and Associates 2009 National Pharmacy StudySM.

21 Sep 2009

Technology News and Research

Navicure adds two Minnesota-based organizations to its client roster

Nanoviricides and Southern Research sign agreement to test anti-Influenza and anti-HIV drug candidates

Memorial Medical Center deploys Motorola's 802.11n WLAN solution to improve patient care

Geron and Corning develop synthetic surface that supports the growth and differentiation of hESCs

GE Capital deploys $1 billion in the U.S. healthcare market for the first six months of 2009

Phytel releases new version of its web-based Proactive Patient Outreach Solution

Primeradx raises funds for commercialization of their technology

Maxygen completes joint venture transaction with Astellas Pharma

Two new products released by Simbionix USA Corporation

BRS Labs announces a video-surveillance technology that processes visual data like human brain

Study reveals that Europe must change perspectives towards food security

Sandia National Laboratories awards equipment contract to Arrayit Corporation

NIAID awards DOR BioPharma a $9M grant to develop thermostable and rapidly acting vaccines

Failures in Canadian health policy

AstraZeneca and Nektar Therapeutics enter worldwide license agreement for two drug development programmes

NIAID awards Antigen Discovery a Phase II STTR grant for Chlamydia vaccine development

Optimized diabetes management with the CONTOUR(R) USB blood glucose meter

Better visualization of soft tissues using Toshiba's LCI

Ontarians support research involving biotechnology

The 2009 National Pharmacy Study ranks Prescription Solutions second among mail order pharmacies

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News